Rifaximin, a rifamycin derivative for use in the treatment of intestinal bacterial infections in seriously disabled patients
- PMID: 3817281
- DOI: 10.1177/030006058701500106
Rifaximin, a rifamycin derivative for use in the treatment of intestinal bacterial infections in seriously disabled patients
Abstract
This study reports the results of an evaluation of the effectiveness and tolerability of rifaximin, an intestinal topical antibiotic. It was administered using a nasogastric tube in patients with severe enterocolitis and bacterial superinfections causing intestinal inflammatory diseases and portosystemic encephalopathy. The drug proved highly effective clinically and produced neither local nor systemic side-effects.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
